<DOC>
	<DOCNO>NCT01183559</DOCNO>
	<brief_summary>The purpose study determine tolerable safe dose ZD6474 ( Zactima ) give standard chemotherapy , radiation therapy surgery patient cancer esophagus</brief_summary>
	<brief_title>A Trial ZD6474 ( Zactima ) , Paclitaxel , Carboplatin , 5-Fluorouracil , XRT Followed Surgery</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Inclusion criterion : Histologically document carcinoma esophagus , gastroesophageal junction , stomach chemo/radiation therapy appropriate . Potentially resectable esophageal , GE junction carcinoma , stomach carcinoma ECOG PS = 02 No evidence distant metastases Age 18 great Signed informed consent Willingness practice adequate contraception woman childbearing potential . Contraception must continue one month follow discontinuation study drug . Female patient childbearing potential ( WOCBP ) must negative pregnancy test within 7 day first treatment . WOCBP include female experience menarche undergone successful surgical sterilization ( hysterectomy , bilateral tubal ligation , bilateral oophorectomy ) postmenopausal ( define amenorrhea &gt; =12 consecutive month , woman hormone replacement therapy ( HRT ) document plasma folliclestimulating hormone ( FSH ) level &gt; 35 mIU/mL ) . Even woman use oral , implanted , injectable contraceptive hormone mechanical product ( diaphragm , condom , spermicide ) prevent pregnancy practice abstinence partner sterile ( e.g . vasectomy ) , consider WOCBP . Should woman become pregnant suspect pregnant participating study , inform treat physician immediately . Exclusion criterion : Previous radiation therapy chest upper abdomen . Evidence severe uncontrolled systemic disease concurrent condition Investigator 's opinion make undesirable patient participate trial would jeopardize compliance protocol . Impaired cardiac function baseline , include follow : Clinically significant cardiac event myocardial infarction ; New York Heart Association ( NYHA ) classification heart disease &gt; 2 ( see Appendix A ) within 3 month registration ; presence cardiac disease , opinion Investigator , increase risk ventricular arrhythmia . Inadequate pulmonary cardiac function tolerate surgery ( see section 12 ) : leave ventricular ejection fraction &lt; 45 % and/or positive stress test ; Forced Expiratory Volume ( FEV1 ) &lt; 1.1 liter . History arrhythmia ( multifocal premature ventricular contraction ( PVCs ) , bigeminy , trigeminy , ventricular tachycardia , uncontrolled atrial fibrillation ) symptomatic require treatment ( CTCAE grade 3 ) asymptomatic sustain ventricular tachycardia . Atrial fibrillation , control medication exclude . Previous history QTc prolongation result medication require discontinuation medication . Congenital long QT syndrome , 1st degree relative unexplained sudden death 40 year age . Presence leave bundle branch block ( LBBB ) . QTc Bazett 's correction unmeasurable , &gt; or= 480 msec screen ECG . If patient QTc &gt; or= 480 msec screen ECG , screen ECG may repeat twice ( least 24 hour apart ) . The average QTc three screen ECGs must &lt; 480 msec order patient eligible study ) . Any concomitant medication may cause QTc prolongation , induce Torsades de Pointes induce CYP3A4 function ( see Appendix B ) Hypertension control medical therapy ( systolic blood pressure great 160 mm Hg diastolic blood pressure great 100 mm Hg ) Women currently pregnant breast feeding . Previous current malignancy within last 5 year , exception cervical carcinoma situ adequately treat basal cell squamous cell carcinoma skin Receipt investigational agent within 30 day prior commence study treatment . Uncontrollable diarrhea may affect ability patient absorb ZD 6474 tolerate sideeffects . Laboratory result : Adequate bone marrow function define granulocyte count &lt; 1500/mm3 platelet count &lt; 100,000 Serum bilirubin &gt; 1.5x upper limit reference range ( ULRR ) Serum creatinine &gt; 1.5 x ULRR creatinine clearance &lt; 50 mL/minute ( calculate CockcroftGault formula . ) Potassium &lt; 4.0 mmol/L despite supplementation ; serum calcium ( ionize adjust albumin , ) magnesium normal range despite supplementation . Alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) &gt; 2.5 X ULRR</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>